Search results
Eli Lilly stock hits all-time high: What’s been driving the pharma giant’s share price higher?
Bankrate via Yahoo Finance· 19 hours agoJ.P. Morgan Research forecasts that the GLP...While Lilly is working through supply chain issues as...
Is Eli Lilly the Best Pharmaceutical Stock for You?
The Motley Fool via AOL· 1 day agoAs for the current products, they both are essentially the same drug: tirzepatide. But regulators...the compound under the name Mounjaro in 2022 for type...
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
Investor's Business Daily· 23 hours agoRevenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over $50...
Eli Lilly and Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings) - Eli Lilly and Co...
Benzinga· 14 hours agoLilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz ...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Motley Fool via Yahoo Finance· 2 days agoHowever, the title now belongs to Eli Lilly (NYSE: LLY) -- and it isn't even close. Lilly continues...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 2 days agoWith its stock price fast approaching $1000 per share, drugmakerEli lilly is poised for a forward...
Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co (NYSE:LLY)
Benzinga· 3 days agoLilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz ...
Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance?
Motley Fool via Yahoo Finance· 6 days agoEli Lilly (NYSE: LLY) shares have soared more than 87% over the past year, making this player...with...
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
The Motley Fool via AOL· 23 hours agoEli Lilly Eli Lilly (NYSE: LLY) is a global pharmaceutical company focused on developing innovative...
Google's new CFO, Anat Ashkenazi, raked in a nearly $10 million signing bonus
Business Insider via Yahoo News· 4 days agoDuring Ashkenazi's tenure, Eli Lilly has achieved a market cap of more than $800 billion, largely...